tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VYGR Stock Latest News

Voyager Therapeutics: Strategic Positioning and Promising Pipeline Drive Buy Rating
RatingsVoyager Therapeutics: Strategic Positioning and Promising Pipeline Drive Buy Rating
2d ago
VYGR
Voyager Therapeutics Extends Cash Runway to 2028
PremiumCompany Announcements
Voyager Therapeutics Extends Cash Runway to 2028
3d ago
VYGR
Voyager Therapeutics: Strategic Restructuring and Pipeline Progress Underpin Buy Rating
PremiumRatings
Voyager Therapeutics: Strategic Restructuring and Pipeline Progress Underpin Buy Rating
8d ago
VYGR
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating
PremiumRatings
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating
9d ago
VYGR
Voyager Therapeutics price target lowered to $8 from $9 at Wedbush
PremiumThe Fly
Voyager Therapeutics price target lowered to $8 from $9 at Wedbush
9d ago
VYGR
Voyager Therapeutics reports Q2 EPS (57c), consensus (52c)
PremiumThe FlyVoyager Therapeutics reports Q2 EPS (57c), consensus (52c)
9d ago
VYGR
Buy Rating for Voyager Therapeutics Driven by Promising Alzheimer’s Gene Therapy and Significant Share Price Potential
Premium
Ratings
Buy Rating for Voyager Therapeutics Driven by Promising Alzheimer’s Gene Therapy and Significant Share Price Potential
1M ago
VYGR
Voyager Therapeutics continues expansion of its AD franchise
Premium
The Fly
Voyager Therapeutics continues expansion of its AD franchise
1M ago
VYGR
Voyager Therapeutics’ Promising Alzheimer’s Study: A Potential Game-Changer?
PremiumCompany Announcements
Voyager Therapeutics’ Promising Alzheimer’s Study: A Potential Game-Changer?
1M ago
VYGR
Voyager Therapeutics Approves Stock Plans at Annual Meeting
PremiumCompany Announcements
Voyager Therapeutics Approves Stock Plans at Annual Meeting
2M ago
8K
VYGR
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks
3M ago
TVRD
VYGR
Voyager Therapeutics demonstrates ALPL receptor-mediated BBB transport
PremiumThe Fly
Voyager Therapeutics demonstrates ALPL receptor-mediated BBB transport
3M ago
VYGR
Voyager Therapeutics: Promising Pipeline and Financial Stability Justify Buy Rating
PremiumRatingsVoyager Therapeutics: Promising Pipeline and Financial Stability Justify Buy Rating
3M ago
VYGR
Voyager Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Voyager Therapeutics Reports Q1 2025 Financial Results
3M ago
VYGR
Voyager Therapeutics: Undervalued Growth Potential Amidst Strong Financials and Strategic Advancements
Premium
Ratings
Voyager Therapeutics: Undervalued Growth Potential Amidst Strong Financials and Strategic Advancements
3M ago
VYGR
Voyager Therapeutics: Promising Future Prospects with Strong Financial Position and Innovative Pipeline
PremiumRatings
Voyager Therapeutics: Promising Future Prospects with Strong Financial Position and Innovative Pipeline
3M ago
VYGR
Voyager Therapeutics: Strong Financial Position and Promising Developmental Outlook Justify Buy Rating
PremiumRatings
Voyager Therapeutics: Strong Financial Position and Promising Developmental Outlook Justify Buy Rating
3M ago
VYGR
Positive FDA Interactions and Strong Financial Position Drive Buy Rating for Voyager Therapeutics
PremiumRatings
Positive FDA Interactions and Strong Financial Position Drive Buy Rating for Voyager Therapeutics
3M ago
VYGR
Voyager Therapeutics reports Q1 EPS (53c), consensus (44c)
PremiumThe Fly
Voyager Therapeutics reports Q1 EPS (53c), consensus (44c)
3M ago
VYGR
Promising Developments in Alzheimer’s Treatments Support Buy Rating for Voyager Therapeutics
PremiumRatingsPromising Developments in Alzheimer’s Treatments Support Buy Rating for Voyager Therapeutics
4M ago
VYGR
Promising Developments in Voyager Therapeutics’ Alzheimer’s Programs Highlight Potential of Dual Tau-Targeted Therapies
Premium
Ratings
Promising Developments in Voyager Therapeutics’ Alzheimer’s Programs Highlight Potential of Dual Tau-Targeted Therapies
4M ago
VYGR
Voyager updates on Alzheimer’s programs ‘compelling,’ says H.C. Wainwright
Premium
The Fly
Voyager updates on Alzheimer’s programs ‘compelling,’ says H.C. Wainwright
4M ago
VYGR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >